| Name | Title | Contact Details |
|---|---|---|
Liam Pickett |
Head of National Sales, Patient and Testing | Profile |
Abhishek Jain |
Chief Financial Officer - Interim | Profile |
Lexi Bojansky |
Regional Sales Director | Profile |
Curt Lind |
Vice President, Head of Research & Development - Lab Products | Profile |
Dustin Leach |
Vice President Customer Experience | Profile |
Ankyra is developing cancer therapies based on localized cytokines that prime a systemic adaptive immune response.
Theralogix is a Holmes, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Pascal Biosciences is a biotechnology company focused on advancing innovative approaches for the treatment of cancer including cannabinoid-based therapeutics and targeted therapies. The company`s leading cannabinoid portfolio comprises a small molecule therapeutic, ST-403, that is advancing into clinical trials for the treatment of glioblastoma, and an immuno-stimulatory molecule. In addition, Pascal Biosciences is developing a B-cell targeted antibody for acute lymphoblastic leukemia and an antibody for calcium channels expressed by the immune system. Pascal is headquartered in Vancouver, Canada. The company trades on the TSX Venture Exchange under the symbol “PAS”.
Dren Bio is a San Carlos, CA based biotechnology company, developing power protein-based technologies to deplete pathogenic cells and agents in numerous diseases.